Table 1 Clinical and pathologic features in 196 patients with renal cell carcinoma.
Features | Clear cell carcinoma | Papillary carcinoma | All subtypesa |
|---|---|---|---|
No. of cases | 172 (87.8) | 19 (9.7) | 196 (100) |
Mean age (years) | 66.6 | 62.4 | 66.4 |
Gender | |||
n Male/Female | 95/77 | 13/6 | 110/86 (56.1) |
Pathologic tumour size (cm) | |||
Median (range) | 7.0 (1.5 – 26.0) | 8 (3.0–20.0) | 7 (1.5 – 26.0) |
Mode of presentation | |||
Symptomatic/Incidental | 144/28 | 17/2 | 165/31 (84.2) |
ECOG performance status: | |||
0 | 109 (63.4) | 12 (63.2) | 125 (63.8) |
1 | 52 (30,2) | 6 (31.6) | 58 (29.6) |
2 | 11 (6.4) | 1 (5.3) | 13 (6.6) |
ESR | |||
< 28 mm | 88 (51.2) | 10 (52.5) | 103 (52.6) |
≥ 28 mm | 84 (48.8) | 9 (47.3) | 95 (48.5) |
RCC Stage groups (TNM, 2002) | |||
I | 52 (30.2) | 7 (36,8) | 62 (31.6) |
II | 24 (14.0) | 5 (26,3) | 29 (14.8) |
III | 48 (27.9) | 3 (15.8) | 53 (27.0) |
IV | 48 (27.9) | 4 (21.1) | 52 (27.0) |
Primary pathological tumour stage (pT, 2002) | |||
pT1a | 18 (10.5) | 3 (15,8) | 22 (11.2) |
pT1b | 39 (22.7) | 5 (26.3) | 46 (23.5) |
pT2 | 28 (16.3) | 6 (31.6) | 34 (17.3) |
pT3a | 28 (16.3) | 0 (0) | 29 (14.8) |
pT3b | 48 (28.0) | 5 (26.3) | 54 (27.6) |
pT3c | 0 (0) | 0 (0) | 0 (0) |
pT4 | 11 (6.4) | 0 (0) | 11 (5.6) |
Pathologic stage of lymph nodes (N, 2002) | |||
pN x | 141 (82.0) | 15 (79.0) | 161 (82.1) |
pN 0 | 14 (8.1) | 0 (0) | 14 (7.1) |
pN 1 | 10 (5.8) | 2 (11.0) | 12 (6.1) |
pN 2 | 7 (4.1) | 2 (11.0) | 9 (4.6) |
SDM (M, 2002) | |||
M 0 | 131 (76.1) | 15 (79.0) | 151 (77.0) |
M + (single) | 9 (5.2) | 1 (5.3) | 10 (5.1) |
M + (multiple) | 32 (18.6) | 3 (15.8) | 35 (17.9) |
Venous invasion (VI = pV1+pV2) | |||
pV 0 | 122 (70.9) | 14 (73.7) | 140 (71.4) |
pV 1 (renal vein) | 36 (20.9) | 4 (21.1) | 41 (20.9) |
pV 2 (vena cava) | 14 (8.1) | 1 (5.3) | 15 (7.7) |